Commentary Open Access
Volume 3 | Issue 6 | DOI: https://doi.org/10.33696/immunology.3.121
Application of Mucosal Immune-related Molecular Adjuvants CCL19 and CCL28 in Enhancing the Function of HSV-2 gD DNA Vaccine
Yan Yan1,*, Xu Wang2, Renfang Chen1,*
- 1Infection and Immunity Laboratory, The Fifth People’s Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi,China
- 2Center of Clinical Laboratory, The Fifth People’s Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China
Corresponding Author
Yan Yan, yanyan198134@hotmail.com; Renfang Chen, 1094825330@qq.com
Received Date: July 30, 2021
Accepted Date: November 30, 2021
Citation:
Yan Y, Wang X, Chen R. Application of Mucosal Immune-related Molecular Adjuvants CCL19 and CCL28 in Enhancing the Function of HSV-2 gD DNA Vaccine. J Cell Immunol. 2021;3(6):380-386.
Copyright: © 2021 Yan Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
HSV-2, Glycoprotein D, Mucosal Immunity, Molecular Adjuvant, CCL19, CCL28